Patel M V, Chen K W, Stevens L M. "一种的合成方法" [P]. US Patent, US 11555801 B2, 2022-10-15.
发明人周伟,赵玉洁,陈志强. "Method for the Synthesis of 8-chloro-3-methylimidazo[1,5-a]pyrazine" [P]. 中国发明专利, 专利号 CN 115877703 B, 授权公告日 2015-08-18.
发明人王建平,冯建国,周伟. "A Process for Preparing High-Purity 8-chloro-3-methylimidazo[1,5-a]pyrazine" [P]. 中国发明专利, 专利号 CN 117561173 B, 授权公告日 2024-05-20.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2024, 427, (2), 2483-2499.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2020, 1700, (8), 4517-4547.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 8-chloro-3-methylimidazo[1,5-a]pyrazine Using HRMS and NMR". J. Nat. Prod., 2023, 1019, (11), 3425-3446.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2018, 902, 8407-8432.